|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0013216,
umls-concept:C0042670,
umls-concept:C0205195,
umls-concept:C0205263,
umls-concept:C0205314,
umls-concept:C0205420,
umls-concept:C0442711,
umls-concept:C0596545,
umls-concept:C0679622,
umls-concept:C0684249,
umls-concept:C0936012,
umls-concept:C1522449,
umls-concept:C1559154
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-7-15
|
|
pubmed:abstractText |
The London Regional Cancer Program (LRCP) uses a unique schedule of induction plus concurrent chemoradiation, termed VCRT (vinblastine, cisplatin, and radiation therapy), for the treatment of a subset of unresectable stage IIIA and IIIB non-small-cell lung cancer (NSCLC). This analysis was conducted to better understand the outcomes in VCRT-treated patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1938-0690
|
|
pubmed:author |
pubmed-author:AshRobertR,
pubmed-author:DarRashidR,
pubmed-author:DingleBrianB,
pubmed-author:InculetRichardR,
pubmed-author:KochaWalterW,
pubmed-author:MalthanerRichardR,
pubmed-author:SanataniMichaelM,
pubmed-author:StittLarryL,
pubmed-author:VincentMarkM,
pubmed-author:WatersEugenieE,
pubmed-author:YaremkoBrianB,
pubmed-author:YounusJawaidJ,
pubmed-author:YuEdwardE,
pubmed-author:ZhaoJiaweiJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
243-50
|
|
pubmed:meshHeading |
pubmed-meshheading:20630826-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20630826-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20630826-Cisplatin,
pubmed-meshheading:20630826-Cohort Studies,
pubmed-meshheading:20630826-Combined Modality Therapy,
pubmed-meshheading:20630826-Follow-Up Studies,
pubmed-meshheading:20630826-Humans,
pubmed-meshheading:20630826-Lung Neoplasms,
pubmed-meshheading:20630826-Neoplasm Staging,
pubmed-meshheading:20630826-Radiotherapy Dosage,
pubmed-meshheading:20630826-Remission Induction,
pubmed-meshheading:20630826-Retrospective Studies,
pubmed-meshheading:20630826-Survival Rate,
pubmed-meshheading:20630826-Treatment Outcome,
pubmed-meshheading:20630826-Vinblastine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Analysis of a novel protocol of combined induction chemotherapy and concurrent chemoradiation in unresected non-small-cell lung cancer: a ten-year experience with vinblastine, Cisplatin, and radiation therapy.
|
|
pubmed:affiliation |
University of Western Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
